Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Dec 12, 2019
Tools & Techniques

New hepatic stellate cell subset drives liver fibrosis

Single-cell sequencing to inform design of targeted liver fibrosis therapies
BioCentury | Jan 3, 2019
Distillery Therapeutics

Cancer

BioCentury | Jul 25, 2018
Distillery Therapeutics

Cancer

BioCentury | Oct 27, 2016
Distillery Therapeutics

Cancer

BioCentury | Feb 25, 2016
Strategy

Changing the channel

A new open-science platform aims to spotlight reproducibility
BioCentury | Aug 17, 2015
Company News

Mylan sales and marketing update

BioCentury | Jul 16, 2015
Distillery Therapeutics

Therapeutics: Retinoid X receptor (RXR)

Items per page:
1 - 10 of 93